This activity will explore appropriate use of opioid therapies in pain, where opioids fit in a comprehensive treatment plan that included non-pharmacologic and non-opioid strategies, and the role of a clinician in the safe prescribing of opioid medications to patients in acute or chronic pain. This activity will not cover palliative care or end-of-life care patients in depth. In addition, this activity will address the risks and benefits of this class of medications and the tools needed to properly evaluate a patient’s pain and risk of misuse. To ensure the best possible outcomes for patients, this program will cover the entire FDA Opioid Analgesic REMS Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients with Pain. Each Blueprint element will tie into a real-life patient case that the learner will explore and assist in the safe and effective treatment, from initial visit to managing follow-up.

Provided by MediCom Worldwide, Inc.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration.